Sharon N Edmiston

6PUBLICATIONS
85CO-AUTHORS
Predictive and prognostic markersEpigenetics (incl. genome methylation and epigenomics)Medical mycologyGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 12, 2026
Chromatin architecture and physical constriction cooperate in phenotype switching and cancer cell dissemination.

Pietro Berico, Cody Dunton, Luay Almassalha

|Oct 20, 2025
Tumor miRNA Signatures Associate with Outcomes of Patients with Stage II/III Melanoma.

Jennifer M Wiggins, Qiao Zhang, Yian Zhang

|Mar 04, 2025
Association of Inherited Genetic Variants with Multiple Primary Melanoma.

David C Gibbs, Brittany M Small, Isidora Autuori

|Nov 07, 2024
DNA Methylation Classes of Stage II and III Primary Melanomas and Their Clinical and Prognostic Significance.

Kathleen Conway, Sharon N Edmiston, Amanda Vondras

|Mar 17, 2023
Pathway Alterations in Stage II/III Primary Melanoma.

Caroline E Kostrzewa, Li Luo, Arshi Arora

|Oct 05, 2021
Disease-Associated Risk Variants in <i>ANRIL</i> Are Associated with Tumor-Infiltrating Lymphocyte Presence in Primary Melanomas in the Population-Based GEM Study.

Danielle R Davari, Irene Orlow, Peter A Kanetsky

Pageof 1

Frequent Collaborators

5 joint publications

Irene Orlow

5 joint publications

Eva Hernando-Monge

4 joint publications

Anne E Cust

4 joint publications

Nancy E Thomas